Armata Pharmaceuticals (ARMP) Operating Margin (2016 - 2018)
Historic Operating Margin for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to 829.08%.
- Armata Pharmaceuticals' Operating Margin rose 126540800.0% to 829.08% in Q4 2018 from the same period last year, while for Dec 2018 it was 1127.68%, marking a year-over-year increase of 151763700.0%. This contributed to the annual value of 762.14% for FY2024, which is 29108500.0% up from last year.
- Per Armata Pharmaceuticals' latest filing, its Operating Margin stood at 829.08% for Q4 2018, which was up 126540800.0% from 791.21% recorded in Q3 2018.
- Armata Pharmaceuticals' 5-year Operating Margin high stood at 1011.74% for Q2 2018, and its period low was 53927.27% during Q4 2016.
- Over the past 5 years, Armata Pharmaceuticals' median Operating Margin value was 2571.29% (recorded in 2014), while the average stood at 8068.94%.
- As far as peak fluctuations go, Armata Pharmaceuticals' Operating Margin surged by 729546900bps in 2014, and later crashed by -516304000bps in 2016.
- Over the past 5 years, Armata Pharmaceuticals' Operating Margin (Quarter) stood at 2571.29% in 2014, then grew by 11bps to 2296.88% in 2015, then tumbled by -2248bps to 53927.27% in 2016, then skyrocketed by 78bps to 11825.0% in 2017, then surged by 107bps to 829.08% in 2018.
- Its Operating Margin was 829.08% in Q4 2018, compared to 791.21% in Q3 2018 and 1011.74% in Q2 2018.